An exploration of strategies adopted by pharmaceutical companies in Kenya to achieve sustainable competitive advantage

Simple item page
dc.contributor.authorMunene, Winnie (Dr.)
dc.date.accessioned2016-07-05T13:58:13Z
dc.date.available2016-07-05T13:58:13Z
dc.date.issued2016
dc.descriptionA Thesis submitted in partial fulfillment of the requirements for the degree of Master of Business Administration in Healthcare Managementen_US
dc.description.abstractCompetitive strategies are a broad range of strategies firms resort to in order to cope with competition, beat competition or keep ahead of competitors. In the pharmaceutical industry in Kenya, pharmaceuticals companies have developed competitive advantage that was only short lived due to quick imitation by fellow competitors especially companies manufacturing generic products. This study sought to determine strategies adopted by pharmaceutical companies in Kenya to develop sustainable competitive advantage, to describe the internal organizational capabilities contributing to pharmaceutical companies in Kenya competitive advantage, to analyze the external environmental factors influencing pharmaceutical companies in Kenya competitive advantage. The study adopted a descriptive survey design. The study population comprised of 25 Pharmaceutical companies in Kenya. Purposive Sampling was used to select two senior employees in each pharmaceutical company from the finance and operation department, thus a sample size of 50 respondents. Primary data was collected using pre-determined questionnaires. Quantitative data collected was analyzed by the use of descriptive statistics using SPSS and presented through percentages, means, standard deviations and frequencies. Multiple regression analysis was conducted. The study found that the strategies adopted by pharmaceutical companies in view of developing sustainable competitive advantage include cost leadership strategy, product differentiation strategy, market focus, as well as investment in research. Among the external organizational capabilities include strategic customer targeting, evaluating organizational strengths and exploring market niches. The internal organizational capabilities contributing sustainable competitive advantage pharmaceutical companies include, investment in staff development, resource allocative efficiency, maintenance of quality accounting standards. This study recommends that differentiation strategy should be highly adopted in order to promote organizational performance, that organizations should highly adopt cost leadership strategy and should periodically conduct SWOT analysis as this will be helpful in establishing business objectives and achieving the organization’s mission, vision and goals.en_US
dc.identifier.urihttp://hdl.handle.net/11071/4590
dc.language.isoenen_US
dc.publisherStrathmore Universityen_US
dc.subjectCompetitionen_US
dc.subjectPharmaceuticalsen_US
dc.subjectKenyaen_US
dc.subjectCompetitive advantageen_US
dc.subjectCompetitive strategyen_US
dc.titleAn exploration of strategies adopted by pharmaceutical companies in Kenya to achieve sustainable competitive advantageen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Winnie Munene.pdf
Size:
890.36 KB
Format:
Adobe Portable Document Format
Description:
Full text thesis
Download
Collections
MBA-HCM Theses and Dissertations (2016)